Systematic pan-cancer analysis of the potential tumor diagnosis and prognosis biomarker P4HA3 (vol 14, 1045061, 2023)

被引：0

作者：

Wu, Yinteng ^{[1
]}

Zhang, Bo ^{[2
]}

Nong, Juan ^{[3
]}

Rodriguez, Raquel Alarcon ^{[4
]}

Guo, Wenliang ^{[5
]}

Liu, Ying ^{[6
]}

Zhao, Shijian ^{[7
]}

Wei, Ruqiong ^{[6
]}

机构：

[1] Guangxi Med Univ, Affiliated Hosp 1, Dept Orthoped & Trauma Surg, Nanning, Guangxi, Peoples R China

[2] Second Nanning Peoples Hosp, Dept Trauma Hand Surg, Nanning, Guangxi, Peoples R China

[3] Second Nanning Peoples Hosp, Dept Joint Surg, Nanning, Guangxi, Peoples R China

[4] Univ Almeria, Fac Hlth Sci, Almeria, Spain

[5] Guigang City Peoples Hosp, Dept Rehabil Med, Guigang, Peoples R China

[6] Guangxi Med Univ, Affiliated Hosp 1, Dept Rehabil Med, Nanning, Guangxi, Peoples R China

[7] Kunming Med Univ, Affiliated Cardiovasc Hosp, Fuwai Yunnan Cardiovasc Hosp, Dept Cardiol, Kunming, Yunnan, Peoples R China

来源：

FRONTIERS IN GENETICS | 2023年 / 14卷

关键词：

prolyl 4-hydroxylase subunit alpha 3 (P4HA3); pan-cancer; the tumor microenvironment (TME); collagen; immunotherapy; epithelial-mesenchymal transition (EMT);

D O I：

10.3389/fgene.2023.1204421

中图分类号：

Q3 [遗传学];

学科分类号：

071007 ; 090102 ;

摘要：

引用

页数：2